Treatment of psoriasis by pulsed dye lasers: short-term and long-term (4 years) results

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN66115464

Enrollment

Registered

2008-09-30

Start date

2002-09-02

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis Skin and Connective Tissue Diseases Psoriasis

Interventions

Two plaques were investigated in each patient, and for both plaques, 1/4 of the total area was left untreated (control area). The remaining area of both plaques were treated with the pulsed dye laser.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Both males and females, minimum age = 18, no upper age limit 2. Psoriasis: chronic and untreated plaques

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Minors 3. Patients who had received local treatment during the last month or oral treatment during the last 6 weeks (cyclosporin, retinoids, methotrexate, corticosteroids)

Design outcomes

Primary

Measure	Time frame
Clinical score at baseline and 6 weeks after the last and third treatment by pulsed dye laser.	—

Secondary

Measure	Time frame
Adverse effects, followed-up for at least 2 years.	—

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026